Efficacy and safety of Once-Daily Vilanterol/Fluticasone furoate MDI in persistent asthma: Phase 3 OD-INHALE Study.
Kumar A, Jain MK, Barge VB, Kumar RS, Gupta N, Yadav H, Pal A, Redkar VE, Mondal A, Rathore RK, Daultani P, Jaiswal A, Mehta RT.
Kumar A, et al. Among authors: daultani p.
J Asthma. 2024 Oct;61(10):1181-1189. doi: 10.1080/02770903.2024.2330485. Epub 2024 Apr 4.
J Asthma. 2024.
PMID: 38488853
Clinical Trial.